Comprehensive Stock Comparison
Compare National Healthcare Properties, Inc. (NHPBP) vs American Healthcare REIT, Inc. (AHR) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | AHR | 11.4% revenue growth vs NHPBP's 2.3% |
| Quality / Margins | AHR | 1.2% net margin vs NHPBP's -23.0% |
| Stability / Safety | NHPBP | Beta 0.44 vs AHR's 0.48 |
| Dividends | AHR | 1.8% yield; NHPBP pays no meaningful dividend |
| Momentum (1Y) | AHR | +78.7% vs NHPBP's +47.6% |
| Efficiency (ROA) | AHR | 0.6% ROA vs NHPBP's -4.6%, ROIC 2.4% vs -4.8% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
National Healthcare Properties is a real estate investment trust that owns and operates healthcare facilities—primarily seniors housing communities and medical office buildings across the United States. It generates revenue through property leases and rental income from healthcare operators, with seniors housing contributing the majority of its portfolio value. The company's competitive advantage lies in its specialized healthcare real estate expertise and diversified portfolio of mission-critical medical properties that benefit from stable, long-term demand.
American Healthcare REIT is a real estate investment trust that owns and operates a diversified portfolio of healthcare properties including medical office buildings, senior housing facilities, and hospitals. It generates revenue primarily through rental income from its healthcare real estate portfolio — with senior housing and medical office buildings being its largest segments — supplemented by management fees from operating certain facilities. The company's competitive advantage lies in its fully integrated management platform with deep industry expertise and long-term relationships in the healthcare real estate sector.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
AHR leads in 3 of 6 categories (Financial Metrics, Profitability & Efficiency). NHPBP leads in 1 (Risk & Volatility).
Financial Metrics (TTM)
AHR is the larger business by revenue, generating $2.2B annually — 6.3x NHPBP's $348M. AHR is the more profitable business, keeping 1.2% of every revenue dollar as net income compared to NHPBP's -23.0%. On growth, AHR holds the edge at +9.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | NHPBPNational Healthca… | AHRAmerican Healthca… |
|---|---|---|
| RevenueTrailing 12 months | $348M | $2.2B |
| EBITDAEarnings before interest/tax | $72M | $378M |
| Net IncomeAfter-tax profit | -$80M | $27M |
| Free Cash FlowCash after capex | -$125M | $269M |
| Gross MarginGross profit ÷ Revenue | +36.2% | +20.7% |
| Operating MarginEBIT ÷ Revenue | -4.2% | +7.7% |
| Net MarginNet income ÷ Revenue | -23.0% | +1.2% |
| FCF MarginFCF ÷ Revenue | -35.9% | +12.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.9% | +9.4% |
| EPS Growth (YoY)Latest quarter vs prior year | — | +11.7% |
Valuation Metrics
| Metric | NHPBPNational Healthca… | AHRAmerican Healthca… |
|---|---|---|
| Market CapShares × price | — | $8.9B |
| Enterprise ValueMkt cap + debt − cash | — | $10.7B |
| Trailing P/EPrice ÷ TTM EPS | — | -180.14x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 75.30x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 29.93x |
| Price / SalesMarket cap ÷ Revenue | — | 4.31x |
| Price / BookPrice ÷ Book value/share | — | 2.96x |
| Price / FCFMarket cap ÷ FCF | — | 106.18x |
Profitability & Efficiency
AHR delivers a 1.0% return on equity — every $100 of shareholder capital generates $1 in annual profit, vs $-12 for NHPBP. AHR carries lower financial leverage with a 0.81x debt-to-equity ratio, signaling a more conservative balance sheet compared to NHPBP's 1.67x. On the Piotroski fundamental quality scale (0–9), AHR scores 7/9 vs NHPBP's 4/9, reflecting strong financial health.
| Metric | NHPBPNational Healthca… | AHRAmerican Healthca… |
|---|---|---|
| ROE (TTM)Return on equity | -12.3% | +1.0% |
| ROA (TTM)Return on assets | -4.6% | +0.6% |
| ROICReturn on invested capital | -4.8% | +2.4% |
| ROCEReturn on capital employed | -7.7% | +4.1% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 |
| Debt / EquityFinancial leverage | 1.67x | 0.81x |
| Net DebtTotal debt minus cash | $1.1B | $1.8B |
| Cash & Equiv.Liquid assets | $22M | $77M |
| Total DebtShort + long-term debt | $1.1B | $1.9B |
| Interest CoverageEBIT ÷ Interest expense | -1.78x | 1.07x |
Total Returns (with DRIP)
A $10,000 investment in AHR five years ago would be worth $41,029 today (with dividends reinvested), compared to $10,678 for NHPBP. Over the past 12 months, AHR leads with a +78.7% total return vs NHPBP's +47.6%. The 3-year compound annual growth rate (CAGR) favors AHR at 60.1% vs NHPBP's 2.9% — a key indicator of consistent wealth creation.
| Metric | NHPBPNational Healthca… | AHRAmerican Healthca… |
|---|---|---|
| YTD ReturnYear-to-date | +7.2% | +10.6% |
| 1-Year ReturnPast 12 months | +47.6% | +78.7% |
| 3-Year ReturnCumulative with dividends | +9.0% | +310.3% |
| 5-Year ReturnCumulative with dividends | +6.8% | +310.3% |
| 10-Year ReturnCumulative with dividends | +6.8% | +310.3% |
| CAGR (3Y)Annualised 3-year return | +2.9% | +60.1% |
Risk & Volatility
NHPBP is the less volatile stock with a 0.44 beta — it tends to amplify market swings less than AHR's 0.48 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | NHPBPNational Healthca… | AHRAmerican Healthca… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.44x | 0.48x |
| 52-Week HighHighest price in past year | $19.11 | $54.67 |
| 52-Week LowLowest price in past year | $11.77 | $26.48 |
| % of 52W HighCurrent price vs 52-week peak | +98.4% | +95.6% |
| RSI (14)Momentum oscillator 0–100 | 48.9 | 73.2 |
| Avg Volume (50D)Average daily shares traded | 6K | 2.3M |
Analyst Outlook
AHR is the only dividend payer here at 1.77% yield — a key consideration for income-focused portfolios.
| Metric | NHPBPNational Healthca… | AHRAmerican Healthca… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $50.43 |
| # AnalystsCovering analysts | — | 11 |
| Dividend YieldAnnual dividend ÷ price | — | +1.8% |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | $0.93 |
| Buyback YieldShare repurchases ÷ mkt cap | — | +0.0% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Mar 24 | Feb 26 | Change |
|---|---|---|---|
| National Healthcare… (NHPBP) | 100 | 114.84 | +14.8% |
| American Healthcare… (AHR) | 103.48 | 359.91 | +247.8% |
American Healthcare… (AHR) returned +310% over 5 years vs National Healthcare… (NHPBP)'s +7%. A $10,000 investment in AHR 5 years ago would be worth $41,029 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2024 | Change |
|---|---|---|---|
| National Healthcare… (NHPBP) | $375M | $354M | -5.6% |
| American Healthcare… (AHR) | $980M | $2.1B | +111.2% |
American Healthcare REIT, Inc.'s revenue grew from $980M (2016) to $2.1B (2024) — a 9.8% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2024 | Change |
|---|---|---|---|
| National Healthcare… (NHPBP) | -23.4% | -53.6% | -128.7% |
| American Healthcare… (AHR) | -14.9% | -1.8% | +87.7% |
American Healthcare REIT, Inc.'s net margin went from -15% (2016) to -2% (2024).
Chart 4EPS Growth — 10 Years
| Stock | 2016 | 2024 | Change |
|---|---|---|---|
| National Healthcare… (NHPBP) | 0 | 0 | — |
| American Healthcare… (AHR) | -3.01 | -0.29 | +90.4% |
American Healthcare REIT, Inc.'s EPS grew from $-3.01 (2016) to $-0.29 (2024).
Chart 5Free Cash Flow — 5 Years
National Healthcare Properties, Inc. generated $-102M FCF in 2024 (-614% vs 2021). American Healthcare REIT, Inc. generated $84M FCF in 2024 (+236% vs 2021).
NHPBP vs AHR: Frequently Asked Questions
7 questions · data-driven answers · updated daily
01Is NHPBP or AHR a better buy right now?
Analysts rate American Healthcare REIT, Inc. (AHR) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — NHPBP or AHR?
Over the past 5 years, American Healthcare REIT, Inc. (AHR) delivered a total return of +310.3%, compared to +6.8% for National Healthcare Properties, Inc. (NHPBP). A $10,000 investment in AHR five years ago would be worth approximately $41K today (assuming dividends reinvested). Over 10 years, the gap is even starker: AHR returned +310.3% versus NHPBP's +6.8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — NHPBP or AHR?
By beta (market sensitivity over 5 years), National Healthcare Properties, Inc. (NHPBP) is the lower-risk stock at 0.44β versus American Healthcare REIT, Inc.'s 0.48β — meaning AHR is approximately 9% more volatile than NHPBP relative to the S&P 500. On balance sheet safety, American Healthcare REIT, Inc. (AHR) carries a lower debt/equity ratio of 81% versus 167% for National Healthcare Properties, Inc. — giving it more financial flexibility in a downturn.
04Which has better profit margins — NHPBP or AHR?
American Healthcare REIT, Inc. (AHR) is the more profitable company, earning -1.8% net margin versus -53.6% for National Healthcare Properties, Inc. — meaning it keeps -1.8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AHR leads at 6.6% versus -34.9% for NHPBP. At the gross margin level — before operating expenses — NHPBP leads at 37.5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
05Which pays a better dividend — NHPBP or AHR?
In this comparison, AHR (1.8% yield) pays a dividend. NHPBP does not pay a meaningful dividend and should not be held primarily for income.
06Is NHPBP or AHR better for a retirement portfolio?
For long-horizon retirement investors, American Healthcare REIT, Inc. (AHR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.48), 1.8% yield, +310.3% 10Y return). Both have compounded well over 10 years (AHR: +310.3%, NHPBP: +6.8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
07What are the main differences between NHPBP and AHR?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. AHR pays a dividend while NHPBP does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.